European commission (ec) approves henlius and organon's bildyos® (denosumab) and bilprevda® (denosumab), biosimilars to prolia (denosumab) and xgeva (denosumab), respectively

Shanghai & jersey city, n.j.--(business wire)--european commission approves henlius and organon's bildyos® (denosumab) and bilprevda® (denosumab), biosimilars.

EC Ratings Summary

EC Quant Ranking